The Role of Human Gut Microbe Ruminococcus gnavus in Inflammatory Diseases

Dysbiosis is a prominent factor in numerous inflammatory conditions, with Ruminococcus gnavus, a prevalent gut microbe, implicated in inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), eczema, metabolic disorders, and rheumatic diseases. R. gnavus contributes to inflammation by producing an inflammatory polysaccharide and degrading mucin. The increasing evidence of elevated R. gnavus abundance in various inflammatory conditions suggests its potential as a therapeutic target. Despite this, there are limited studies on treatment strategies targeting R. gnavus. This article provides a comprehensive overview of the association between R. gnavus and diverse inflammatory conditions, highlighting the need for further research to explore effective treatment options against this bacterium.

[1]  Jiwei Jiang,et al.  Mediation of Regional Cerebral Blood Flow in the Relationship between Specific Gut Microbiota and Cognition in Vascular Cognitive Impairment. , 2023, Journal of Alzheimer's disease : JAD.

[2]  E. Litvinova,et al.  Normalization of Deviant Behavior in Muc2+/+ Mice through Dietary Incorporation of Bacillus subtilis Spores , 2023, Progress In Microbes & Molecular Biology.

[3]  Jia‐Feng Wu,et al.  Antagonism Between Gut Ruminococcus gnavus and Akkermansia muciniphila Modulates the Progression of Chronic Hepatitis B , 2023, Cellular and molecular gastroenterology and hepatology.

[4]  I. Bourais,et al.  Bacterial Exopolysaccharides: From Production to Functional Features , 2023, Progress In Microbes & Molecular Biology.

[5]  Learn‐Han Lee,et al.  Detection of multidrug resistant Vibrio parahaemolyticus and anti-Vibrio Streptomyces sp. MUM 178J , 2023, Progress In Microbes & Molecular Biology.

[6]  F. Errachidi,et al.  Streptomyces at the Heart of Several Sectors to Support Practical and Sustainable Applications: A Review , 2023, Progress In Microbes & Molecular Biology.

[7]  Y. Al-Worafi,et al.  A Review of Herbal Treatment for Functional Gastrointestinal Disorders and Infection , 2023, Progress In Microbes & Molecular Biology.

[8]  Lars Engstrand,et al.  Safety and tolerability of frozen, capsulized autologous faecal microbiota transplantation. A randomized double blinded phase I clinical trial , 2023, PloS one.

[9]  N. Ab Mutalib,et al.  Streptomyces learnhanii sp. nov., unveiling a Mangrove-Derived Novel “Modern Actinobacteria” in Malaysia , 2023, Progress In Microbes & Molecular Biology.

[10]  Jodi Woan‐Fei Law,et al.  The Ameliorative Role of Probiotics in 5-fluorouracil Induced Intestinal Mucositis , 2023, Progress In Microbes & Molecular Biology.

[11]  H. Forssberg,et al.  Early-life differences in the gut microbiota composition and functionality of infants at elevated likelihood of developing autism spectrum disorder , 2023, Translational psychiatry.

[12]  A. Bouyahya,et al.  Evaluation of Antioxidant and Antimicrobial Activity of Saponin Extracts from Different Parts of Argania spinosa L. Skeels , 2023, Progress In Microbes & Molecular Biology.

[13]  Kok-Gan Chan,et al.  A Keystone Gut Bacterium Christensenella minuta—A Potential Biotherapeutic Agent for Obesity and Associated Metabolic Diseases , 2023, Foods.

[14]  Learn‐Han Lee,et al.  IDDF2023-ABS-0316 Exploring the covid-19 vaccination on autoimmune disease and probiotic administration in alleviating disease severity , 2023, Basic Hepatology.

[15]  Maciej Banach,et al.  Nutrition, Nutraceuticals and Bioactive Compounds in the Prevention and Fight against Inflammation , 2023, Nutrients.

[16]  M. Lauritsen,et al.  Children and adolescents with attention deficit hyperactivity disorder and autism spectrum disorder share distinct microbiota compositions , 2023, Gut microbes.

[17]  Learn‐Han Lee,et al.  Whole-Genome Sequence of Streptomyces pluripotens strain MUM 16J, a Potential Resource of Glycopeptide Antibiotic and Biocontrol Agent against Biofilm-forming Bacteria , 2023, Progress In Microbes & Molecular Biology.

[18]  N. Hinata,et al.  A case of bloodstream infection caused by Ruminococcus gnavus without gastrointestinal involvement , 2023, Heliyon.

[19]  Kar-Wai Hong,et al.  COVID-19: An Update on the Latest Therapeutic Agents , 2023, Progress In Microbes & Molecular Biology.

[20]  D. Zeraatkar,et al.  Safety and efficacy of probiotic supplements as adjunctive therapies in patients with COVID-19: A systematic review and meta-analysis , 2023, PloS one.

[21]  L. Ming,et al.  COVID-19 Pandemic in Brunei Darussalam , 2023, Progress In Microbes & Molecular Biology.

[22]  M. Tabyaoui,et al.  Bioactivity of Walnut: Investigating the Triterpenoid Saponin Extracts of Juglans regia Kernels for Antioxidant, Anti-diabetic, and Antimicrobial Properties , 2023, Progress In Microbes & Molecular Biology.

[23]  Kok-Gan Chan,et al.  Probiotics: Comprehensive Exploration of the Growth Promotion Mechanisms in Shrimps , 2023, Progress In Microbes & Molecular Biology.

[24]  Jodi Woan‐Fei Law,et al.  Exploring the impact of Helicobacter pylori and potential gut microbiome modulation , 2023, Progress In Microbes & Molecular Biology.

[25]  Jodi Woan‐Fei Law,et al.  Gut Microbiome in Obsessive Compulsive Disorder: Potential of Probiotics as an Adjuvant Therapy , 2022, Progress In Microbes & Molecular Biology.

[26]  D. Y. Lee,et al.  Gut microbiome alterations in preclinical Alzheimer’s disease , 2022, PloS one.

[27]  Wei Quan Lim,et al.  Role of Garlic in Chronic Diseases: Focusing on Gut Microbiota Modulation , 2022, Progress In Microbes & Molecular Biology.

[28]  Xuangao Wu,et al.  Modulation of the Gut Microbiota in Memory Impairment and Alzheimer’s Disease via the Inhibition of the Parasympathetic Nervous System , 2022, International journal of molecular sciences.

[29]  V. Chen,et al.  Association between Gut Microbiota and Emotional-Behavioral Symptoms in Children with Attention-Deficit/Hyperactivity Disorder , 2022, Journal of personalized medicine.

[30]  Learn‐Han Lee,et al.  IDDF2022-ABS-0221 The roles of GUT microbiota in hand, foot and mouth disease , 2022, Basic Gastroenterology.

[31]  Learn‐Han Lee,et al.  IDDF2022-ABS-0231 The effect of probiotic supplementation in newly diagnosed type-1 diabetes mellitus patient: a systematic review of randomized controlled trials , 2022, Basic Gastroenterology.

[32]  Learn‐Han Lee,et al.  IDDF2022-ABS-0207 The potential use of probiotics in alleviating psychological symptoms of long covid-19 , 2022, Basic Gastroenterology.

[33]  Learn‐Han Lee,et al.  IDDF2022-ABS-0241 Exploring the potential role of probiotics in alleviating insomnia , 2022, Basic Gastroenterology.

[34]  Y. Ishizaki,et al.  Dysbiosis in Gut Microbiota in Children Born Preterm Who Developed Autism Spectrum Disorder: A Pilot Study , 2022, Journal of Autism and Developmental Disorders.

[35]  N. Juge,et al.  The role of the mucin-glycan foraging Ruminococcus gnavus in the communication between the gut and the brain , 2022, Gut microbes.

[36]  Ryan L. Davis,et al.  Nutritional Intake and Gut Microbiome Composition Predict Parkinson’s Disease , 2022, Frontiers in Aging Neuroscience.

[37]  Jodi Woan‐Fei Law,et al.  Long COVID-19: Psychological symptoms in COVID-19 and probiotics as an adjunct therapy , 2022, Progress In Microbes & Molecular Biology.

[38]  M. Levin,et al.  Skin and nasal colonization of coagulase-negative staphylococci are associated with atopic dermatitis among South African toddlers , 2022, PloS one.

[39]  M. Wong,et al.  The gut microbiome and mental health: advances in research and emerging priorities , 2022, Molecular Psychiatry.

[40]  Jodi Woan‐Fei Law,et al.  South Africa’s Battle Against COVID-19 Pandemic , 2022, Progress In Microbes & Molecular Biology.

[41]  D. Cantarero-Prieto,et al.  The effects of gastrointestinal disturbances on the onset of depression and anxiety , 2022, PloS one.

[42]  Learn‐Han Lee,et al.  Psychological Symptoms in COVID-19 Patients: Insights into Pathophysiology and Risk Factors of Long COVID-19 , 2022, Biology.

[43]  S. Ng,et al.  Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome , 2022, Gut.

[44]  K. Swanson,et al.  Weight Loss and High-Protein, High-Fiber Diet Consumption Impact Blood Metabolite Profiles, Body Composition, Voluntary Physical Activity, Fecal Microbiota, and Fecal Metabolites of Adult Dogs. , 2021, Journal of animal science.

[45]  Hooi‐Leng Ser,et al.  COVID-19 Situation in Thailand , 2021, Progress In Microbes & Molecular Biology.

[46]  Xuefeng Gao,et al.  Co‐occurrence of gut microbiota dysbiosis and bile acid metabolism alteration is associated with psychological disorders in Crohn's disease , 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[47]  Jodi Woan‐Fei Law,et al.  Updated COVID-19 Condition in Australia , 2021, Progress In Microbes & Molecular Biology.

[48]  Yurii B. Shvetsov,et al.  Associations of the Dietary Inflammatory Index with total adiposity and ectopic fat through the gut microbiota, lipopolysaccharides, and C-reactive protein in the Multiethnic Cohort-Adiposity Phenotype Study. , 2021, The American journal of clinical nutrition.

[49]  Learn‐Han Lee,et al.  COVID-19: Gastrointestinal Manifestations and Complications , 2021, Progress In Microbes & Molecular Biology.

[50]  S. Khanal,et al.  Biofilm Formation and blaOXA Genes Detection Among Acinetobacter baumannii from Clinical Isolates in a Tertiary Care Kirtipur Hospital, Nepal , 2021, Progress In Microbes & Molecular Biology.

[51]  Y. Shoenfeld,et al.  COVID-19 as an infectome paradigm of autoimmunity , 2021, Journal of Allergy and Clinical Immunology.

[52]  Edoardo Pasolli,et al.  Specific gut microbiome signatures and the associated pro-inflamatory functions are linked to pediatric allergy and acquisition of immune tolerance , 2021, Nature Communications.

[53]  Jagmohan Singh,et al.  Exploration of bioactive peptides from various origin as promising nutraceutical treasures: In vitro, in silico and in vivo studies. , 2021, Food chemistry.

[54]  Jodi Woan‐Fei Law,et al.  Incidence, Antibiotic Susceptibility and Characterization of Vibrio parahaemolyticus Isolated from Seafood in Selangor, Malaysia , 2021, Progress In Microbes & Molecular Biology.

[55]  Kok-Gan Chan,et al.  IDDF2021-ABS-0123 Streptomyces pluripotens MUSC 135T as a treasure trove for anti-colon cancer and anti-MRSA agents , 2021, Basic Gastronenterology.

[56]  N. Ab Mutalib,et al.  Streptomyces sp.—A Treasure Trove of Weapons to Combat Methicillin-Resistant Staphylococcus aureus Biofilm Associated with Biomedical Devices , 2021, International journal of molecular sciences.

[57]  M. Murphy,et al.  Altered Skin and Gut Microbiome in Hidradenitis Suppurativa. , 2021, The Journal of investigative dermatology.

[58]  Zhonghui Ma,et al.  Effects of Smoking on Inflammatory Markers in a Healthy Population as Analyzed via the Gut Microbiota , 2021, Frontiers in Cellular and Infection Microbiology.

[59]  T. Köcher,et al.  Mucosal Biofilms Are an Endoscopic Feature of Irritable Bowel Syndrome and Ulcerative Colitis , 2021, Gastroenterology.

[60]  H. Vlamakis,et al.  Capsular polysaccharide correlates with immune response to the human gut microbe Ruminococcus gnavus , 2021, Proceedings of the National Academy of Sciences.

[61]  Q. Zou,et al.  Ecological and network analyses identify four microbial species with potential significance for the diagnosis/treatment of ulcerative colitis (UC) , 2021, BMC microbiology.

[62]  Jun Wang,et al.  Gut microbiota, inflammation, and molecular signatures of host response to infection. , 2021, Journal of genetics and genomics = Yi chuan xue bao.

[63]  Kok-Gan Chan,et al.  Whole-genome sequence of bioactive streptomycete derived from mangrove forest in Malaysia, Streptomyces sp. MUSC 14 , 2021 .

[64]  L. Lerman,et al.  Compositional change of gut microbiome and osteocalcin expressing endothelial progenitor cells in patients with coronary artery disease , 2021, PloS one.

[65]  Huijun Zhao,et al.  Depicting the composition of gut microbiota in children with tic disorders: an exploratory study. , 2021, Journal of child psychology and psychiatry, and allied disciplines.

[66]  A. Ramadas,et al.  Modulation of gut microbiota by dietary macronutrients in type 2 diabetes: a review , 2021 .

[67]  N. Nagarajan,et al.  Ectopic gut colonization: a metagenomic study of the oral and gut microbiome in Crohn’s disease , 2021, Gut Pathogens.

[68]  R. Ward,et al.  Effect of supplemental prebiotics, probiotics and bioactive proteins on the microbiome composition and fecal calprotectin in C57BL6/j mice. , 2021, Biochimie.

[69]  S. Wong,et al.  The chemistry of gut microbiome in health and diseases , 2021, Progress In Microbes & Molecular Biology.

[70]  I. Chattopadhyay,et al.  Could dysbiosis of inflammatory and anti-inflammatory gut bacteria have an implications in the development of type 2 diabetes? A pilot investigation , 2021, BMC research notes.

[71]  F. Gonzalez,et al.  Pregnane X receptor exacerbates nonalcoholic fatty liver disease accompanied by obesity- and inflammation-prone gut microbiome signature. , 2021, Biochemical pharmacology.

[72]  K. Chow,et al.  Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19 , 2021, Gut.

[73]  M. J. Yebra,et al.  Infant gut microbiota modulation by human milk disaccharides in humanized microbiome mice , 2021, Gut microbes.

[74]  I. Woolley,et al.  A Novel Case of Bilateral Tubo-Ovarian Abscesses Attributed to Ruminococcus gnavus Without Gastrointestinal Involvement. , 2020, Anaerobe.

[75]  M. Fischbach,et al.  Bacterially Derived Tryptamine Increases Mucus Release by Activating a Host Receptor in a Mouse Model of Inflammatory Bowel Disease , 2020, iScience.

[76]  Learn‐Han Lee,et al.  IDDF2020-ABS-0112 Gut-skin axis: decoding the link between the gut microbiome and hives , 2020 .

[77]  E. Zoetendal,et al.  Associations between Pro- and Anti-Inflammatory Gastro-Intestinal Microbiota, Diet, and Cognitive Functioning in Dutch Healthy Older Adults: The NU-AGE Study , 2020, Nutrients.

[78]  U. Gophna,et al.  Dysbiosis in Metabolic Genes of the Gut Microbiomes of Patients with an Ileo-anal Pouch Resembles That Observed in Crohn's Disease , 2020, mSystems.

[79]  F. Fernandez‐Llimos,et al.  Fecal microbiota transplantation in inflammatory bowel disease patients: A systematic review and meta-analysis , 2020, PloS one.

[80]  J. Satsangi,et al.  Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character) , 2020, Scandinavian journal of gastroenterology.

[81]  M. Nagarkatti,et al.  Protective effects of Δ9‐tetrahydrocannabinol against enterotoxin‐induced acute respiratory distress syndrome are mediated by modulation of microbiota , 2020, British journal of pharmacology.

[82]  Zhi Wei,et al.  Paneth Cell-Derived Lysozyme Defines the Composition of Mucolytic Microbiota and the Inflammatory Tone of the Intestine. , 2020, Immunity.

[83]  M. Hattori,et al.  TH1 cell-inducing Escherichia coli strain identified from the small intestinal mucosa of patients with Crohn’s disease , 2020, Gut microbes.

[84]  Wei-Dong Chen,et al.  The Relationship Between Gut Microbiota and Inflammatory Diseases: The Role of Macrophages , 2020, Frontiers in Microbiology.

[85]  S. Wong,et al.  Bioprospecting of Microbes for Valuable Compounds to Mankind , 2020 .

[86]  A. Ramadas,et al.  Dietary Glycaemic Index and Type 2 Diabetes Mellitus: Potential Modulation of Gut Microbiota , 2020 .

[87]  Hong-Wai Tham,et al.  Methicillin-resistant Staphylococcus aureus (MRSA) on dispensing counters of community pharmacies in Klang Valley , 2020 .

[88]  S. Wong,et al.  Role of Low FODMAP Diet and Probiotics on Gut Microbiome in Irritable Bowel Syndrome (IBS) , 2020 .

[89]  Learn‐Han Lee,et al.  PMMB COVID-19 Bulletin: United Kingdom (22nd April 2020) , 2020 .

[90]  Learn‐Han Lee,et al.  PMMB COVID-19 Bulletin: Spain (18th April 2020) , 2020 .

[91]  J. Sim,et al.  Regulatory effects of Lactobacillus plantarum HY7714 on skin health by improving intestinal condition , 2020, PloS one.

[92]  Learn‐Han Lee,et al.  The Rising of “Modern Actinobacteria” Era , 2020 .

[93]  Weihua Yang,et al.  Assessing the efficacy and safety of fecal microbiota transplantation and probiotic VSL#3 for active ulcerative colitis: A systematic review and meta-analysis , 2020, PloS one.

[94]  Guang Yang,et al.  Case-Control Study of the Effects of Gut Microbiota Composition on Neurotransmitter Metabolic Pathways in Children With Attention Deficit Hyperactivity Disorder , 2020, Frontiers in Neuroscience.

[95]  C. Huttenhower,et al.  Gut-resident microorganisms and their genes are associated with cognition and neuroanatomy in children , 2020, bioRxiv.

[96]  U. Gophna,et al.  Predominantly Antibiotic-resistant Intestinal Microbiome Persists in Patients With Pouchitis Who Respond to Antibiotic Therapy. , 2020, Gastroenterology.

[97]  L. Lerman,et al.  Coronary artery disease is associated with an altered gut microbiome composition , 2020, PloS one.

[98]  Learn‐Han Lee,et al.  Critical review of fermentation and extraction of anti-Vibrio compounds from Streptomyces , 2020 .

[99]  J. Flores,et al.  The mitochondrial negative regulator MCJ modulates the interplay between microbiota and the host during ulcerative colitis , 2020, Scientific Reports.

[100]  Yu-Shan Gao,et al.  Effects of dachaihu decoction and its “prescription elements” on intestinal flora of nonalcoholic fatty liver disease model rats , 2020, World Journal of Traditional Chinese Medicine.

[101]  Kok-Gan Chan,et al.  Epinecidin-1, an Antimicrobial Peptide Derived From Grouper (Epinephelus coioides): Pharmacological Activities and Applications , 2019, Front. Microbiol..

[102]  S. Moiseev,et al.  Gut microbiome in rheumatic diseases , 2019, Annals of the Rheumatic Diseases.

[103]  N. Sarvetnick,et al.  Human Islet Response to Selected Type 1 Diabetes-Associated Bacteria: A Transcriptome-Based Study , 2019, Front. Immunol..

[104]  Zhiming Lin,et al.  Variations in gut microbial profiles in ankylosing spondylitis: disease phenotype-related dysbiosis. , 2019, Annals of translational medicine.

[105]  Jan Claesen,et al.  Elucidation of a unique sialic acid metabolism pathway in mucus-foraging Ruminococcus gnavus unravels mechanisms of bacterial adaptation to the gut , 2019, Nature Microbiology.

[106]  L. Andersen,et al.  Ruminococcus gnavus bacteraemia in a patient with multiple haematological malignancies , 2019, Access microbiology.

[107]  M. Nagarkatti,et al.  Resveratrol modulates the gut microbiota to prevent murine colitis development through induction of Tregs and suppression of Th17 cells , 2019, Journal of leukocyte biology.

[108]  Learn‐Han Lee,et al.  The Bioprospecting of Anti-Vibrio Streptomyces species: Prevalence and Applications , 2019, Progress In Microbes & Molecular Biology.

[109]  Claire Duvallet,et al.  Framework for rational donor selection in fecal microbiota transplant clinical trials , 2019, PloS one.

[110]  T. Hennet,et al.  Alleviation of Intestinal Inflammation by Oral Supplementation With 2-Fucosyllactose in Mice , 2019, Front. Microbiol..

[111]  H. Vlamakis,et al.  Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn’s disease, produces an inflammatory polysaccharide , 2019, Proceedings of the National Academy of Sciences.

[112]  S. van Hemert,et al.  Gut feelings: A randomised, triple-blind, placebo-controlled trial of probiotics for depressive symptoms. , 2019, Journal of affective disorders.

[113]  B. Rovin,et al.  Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal , 2019, Annals of the rheumatic diseases.

[114]  J. Satsangi,et al.  Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease – associations with disease phenotype, treatment, and outcome , 2019, Clinical and experimental gastroenterology.

[115]  W. Holzapfel,et al.  Protective effects of Bacillus probiotics against high-fat diet-induced metabolic disorders in mice , 2018, PloS one.

[116]  O. Gilja,et al.  The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation , 2018, PloS one.

[117]  Ben-Yang Liao,et al.  Identification of TMAO-producer phenotype and host–diet–gut dysbiosis by carnitine challenge test in human and germ-free mice , 2018, Gut.

[118]  Kok-Gan Chan,et al.  Streptomyces as a Prominent Resource of Future Anti-MRSA Drugs , 2018, Front. Microbiol..

[119]  A. Drobyshevsky,et al.  Microbiota influence the development of the brain and behaviors in C57BL/6J mice , 2018, PloS one.

[120]  Philip Strandwitz Neurotransmitter modulation by the gut microbiota , 2018, Brain Research.

[121]  S. Salminen,et al.  Pregestational overweight and obesity are associated with differences in gut microbiota composition and systemic inflammation in the third trimester , 2018, PloS one.

[122]  J. Versalovic,et al.  Postnatal colonization with human "infant-type" Bifidobacterium species alters behavior of adult gnotobiotic mice , 2018, PloS one.

[123]  E. Goldstein,et al.  Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis , 2018, Front. Med..

[124]  S. Won,et al.  Perturbations of gut microbiome genes in infants with atopic dermatitis according to feeding type , 2018, The Journal of allergy and clinical immunology.

[125]  Kok-Gan Chan,et al.  Resveratrol—Potential Antibacterial Agent against Foodborne Pathogens , 2018, Front. Pharmacol..

[126]  D. Frank,et al.  Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis , 2018, PloS one.

[127]  B. Geng,et al.  Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients , 2018, Scientific Reports.

[128]  H. Sokol,et al.  Specificities of the intestinal microbiota in patients with inflammatory bowel disease and Clostridium difficile infection , 2018, Gut microbes.

[129]  X. Hou,et al.  Inhibition effect of Bifidobacterium longum, Lactobacillus acidophilus, Streptococcus thermophilus and Enterococcus faecalis and their related products on human colonic smooth muscle in vitro , 2017, PloS one.

[130]  Jun Wang,et al.  Arachidonic acid sex-dependently affects obesity through linking gut microbiota-driven inflammation to hypothalamus-adipose-liver axis. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[131]  L. Shek,et al.  Immune-modulatory genomic properties differentiate gut microbiota of infants with and without eczema , 2017, PloS one.

[132]  M. Nokia,et al.  Intrinsic aerobic capacity governs the associations between gut microbiota composition and fat metabolism age-dependently in rat siblings. , 2017, Physiological genomics.

[133]  Jeroen Raes,et al.  The Gut Microbiome and Mental Health: Implications for Anxiety- and Trauma-Related Disorders. , 2017, Omics : a journal of integrative biology.

[134]  J. Després,et al.  Precision Nutrition: A Review of Personalized Nutritional Approaches for the Prevention and Management of Metabolic Syndrome , 2017, Nutrients.

[135]  Sufang Li,et al.  The changes of gut microbiota after acute myocardial infarction in rats , 2017, PloS one.

[136]  J. Tap,et al.  Faecal microbiota study reveals specific dysbiosis in spondyloarthritis , 2017, Annals of the rheumatic diseases.

[137]  L. Drago,et al.  Effect of Lactobacillus rhamnosus HN001 and Bifidobacterium longum BB536 on the healthy gut microbiota composition at phyla and species level: A preliminary study , 2017, World journal of gastroenterology.

[138]  M. Hattori,et al.  Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure , 2017, PloS one.

[139]  Helen Tremlett,et al.  The gut microbiome in human neurological disease: A review , 2017, Annals of neurology.

[140]  N. Mach,et al.  Exercise-induced stress behavior, gut-microbiota-brain axis and diet: a systematic review for athletes , 2016, Journal of the International Society of Sports Nutrition.

[141]  Huajun Zheng,et al.  Altered Gut Microbiota Composition Associated with Eczema in Infants , 2016, PloS one.

[142]  U. Gophna,et al.  Alterations of Enteric Microbiota in Patients with a Normal Ileal Pouch Are Predictive of Pouchitis , 2016, Journal of Crohn's & colitis.

[143]  Bangmao Wang,et al.  Systematic Review: Adverse Events of Fecal Microbiota Transplantation , 2016, PloS one.

[144]  Lisa C. Crossman,et al.  The mucin-degradation strategy of Ruminococcus gnavus: The importance of intramolecular trans-sialidases , 2016, Gut microbes.

[145]  Michael J. Barratt,et al.  Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children , 2016, Science.

[146]  Kok-Gan Chan,et al.  Streptomyces Bacteria as Potential Probiotics in Aquaculture , 2016, Front. Microbiol..

[147]  L. Robinson,et al.  Diets enriched with cranberry beans alter the microbiota and mitigate colitis severity and associated inflammation. , 2016, The Journal of nutritional biochemistry.

[148]  J. Doré,et al.  Structural robustness of the gut mucosal microbiota is associated with Crohn's disease remission after surgery , 2015, Gut.

[149]  Kok-Gan Chan,et al.  Investigation of Antioxidative and Anticancer Potentials of Streptomyces sp. MUM256 Isolated from Malaysia Mangrove Soil , 2015, Front. Microbiol..

[150]  V. Lionetti,et al.  The Efficacy and Safety of the Probiotic Bacterium Lactobacillus reuteri DSM 17938 for Infantile Colic: A Meta-Analysis of Randomized Controlled Trials , 2015, PloS one.

[151]  K. Van Steen,et al.  Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC , 2015, Gut.

[152]  D. Repsilber,et al.  Cytokine Response after Stimulation with Key Commensal Bacteria Differ in Post-Infectious Irritable Bowel Syndrome (PI-IBS) Patients Compared to Healthy Controls , 2015, PloS one.

[153]  Kok-Gan Chan,et al.  Traditional Uses, Phytochemistry, and Bioactivities of Cananga odorata (Ylang-Ylang) , 2015, Evidence-based complementary and alternative medicine : eCAM.

[154]  H. Sokol,et al.  Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice , 2015, The ISME Journal.

[155]  John Walshaw,et al.  Discovery of intramolecular trans-sialidases in human gut microbiota suggests novel mechanisms of mucosal adaptation , 2015, Nature Communications.

[156]  J. Goedert,et al.  Sex, Body Mass Index, and Dietary Fiber Intake Influence the Human Gut Microbiome , 2015, PloS one.

[157]  S. Nutten Atopic Dermatitis: Global Epidemiology and Risk Factors , 2015, Annals of Nutrition and Metabolism.

[158]  S. Kennedy,et al.  Dietary Patterns Differently Associate with Inflammation and Gut Microbiota in Overweight and Obese Subjects , 2014, PloS one.

[159]  G. Salvador,et al.  Soluble Factors from Lactobacillus reuteri CRL1098 Have Anti-Inflammatory Effects in Acute Lung Injury Induced by Lipopolysaccharide in Mice , 2014, PloS one.

[160]  R. Sartor,et al.  Induction of Bacterial Antigen-Specific Colitis by a Simplified Human Microbiota Consortium in Gnotobiotic Interleukin-10−/− Mice , 2014, Infection and Immunity.

[161]  L. Massimiliano,et al.  Lactobacillus paracasei CBA L74 Metabolic Products and Fermented Milk for Infant Formula Have Anti-Inflammatory Activity on Dendritic Cells In Vitro and Protective Effects against Colitis and an Enteric Pathogen In Vivo , 2014, PloS one.

[162]  M. Fons,et al.  Utilisation of Mucin Glycans by the Human Gut Symbiont Ruminococcus gnavus Is Strain-Dependent , 2013, PloS one.

[163]  E. Veldhuizen,et al.  Chicken Cathelicidins Display Antimicrobial Activity against Multiresistant Bacteria without Inducing Strong Resistance , 2013, PloS one.

[164]  Masayuki Yoshida,et al.  Adipose Inflammation Initiates Recruitment of Leukocytes to Mouse Femoral Artery: Role of Adipo-Vascular Axis in Chronic Inflammation , 2011, PloS one.

[165]  P. Vandamme,et al.  Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives , 2011, Gut.

[166]  U. Göbel,et al.  Anti-Inflammatory Effects of Resveratrol, Curcumin and Simvastatin in Acute Small Intestinal Inflammation , 2010, PloS one.

[167]  Anders F. Andersson,et al.  A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. , 2010, Gastroenterology.

[168]  Y. Agid,et al.  Repetitive Behaviours in Patients with Gilles de la Tourette Syndrome: Tics, Compulsions, or Both? , 2010, PloS one.

[169]  K. Wilson,et al.  Ribosomal DNA Sequence Analysis of Mucosa-Associated Bacteria in Crohn’s Disease , 2004, Inflammatory bowel diseases.

[170]  M. Kawahara,et al.  Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease , 2017, Journal of Gastroenterology.

[171]  Hua Zhu,et al.  Altered Gut Microbiota in a Mouse Model of Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.

[172]  I I Lelis,et al.  [Atopic dermatitis]. , 1980, Vestnik dermatologii i venerologii.